ONCR insider filings
Oncorus, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-12-30. Screen ONCR transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ONCR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Oncorus, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-12-30 | 4 | Flynn James E — 10% owner Deerfield Mgmt HIF, L.P. — 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — 10% owner Deerfield Healthcare Innovations Fund, L.P. — 10% owner Deerfield Mgmt L.P. — 10% owner Deerfield Mgmt III, L.P. — 10% owner Deerfield Private Design Fund III, L.P. — 10% owner DEERFIELD PARTNERS, L.P. — 10% owner | Sale (S): 24,757 @ $0.25 · Sale (S): 24,757 @ $0.25 · Sale (S): 6,096 @ $0.25 · Sale (S): 63,107 @ $0.26 · Sale (S): 63,108 @ $0.26 · Sale (S): 15,538 @ $0.26 · +3 more | EDGAR |
| 2022-12-27 | 4 | Flynn James E — 10% owner Deerfield Mgmt HIF, L.P. — 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — 10% owner Deerfield Healthcare Innovations Fund, L.P. — 10% owner Deerfield Mgmt L.P. — 10% owner Deerfield Mgmt III, L.P. — 10% owner Deerfield Private Design Fund III, L.P. — 10% owner DEERFIELD PARTNERS, L.P. — 10% owner | Sale (S): 3,692 @ $0.28 · Sale (S): 3,693 @ $0.28 · Sale (S): 909 @ $0.28 · Sale (S): 28,977 @ $0.27 · Sale (S): 28,977 @ $0.27 · Sale (S): 7,136 @ $0.27 | EDGAR |
| 2022-12-21 | 4 | Flynn James E — 10% owner Deerfield Mgmt HIF, L.P. — 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — 10% owner Deerfield Healthcare Innovations Fund, L.P. — 10% owner Deerfield Mgmt L.P. — 10% owner Deerfield Mgmt III, L.P. — 10% owner Deerfield Private Design Fund III, L.P. — 10% owner DEERFIELD PARTNERS, L.P. — 10% owner | Sale (S): 44,394 @ $0.29 · Sale (S): 44,394 @ $0.29 · Sale (S): 10,930 @ $0.29 · Sale (S): 6,562 @ $0.31 · Sale (S): 6,562 @ $0.31 · Sale (S): 1,616 @ $0.31 · +3 more | EDGAR |
| 2022-12-15 | 4 | Flynn James E — 10% owner Deerfield Mgmt HIF, L.P. — 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — 10% owner Deerfield Healthcare Innovations Fund, L.P. — 10% owner Deerfield Mgmt L.P. — 10% owner Deerfield Mgmt III, L.P. — 10% owner Deerfield Private Design Fund III, L.P. — 10% owner DEERFIELD PARTNERS, L.P. — 10% owner | Sale (S): 934 @ $0.41 · Sale (S): 933 @ $0.41 · Sale (S): 230 @ $0.41 · Sale (S): 3,828 @ $0.38 · Sale (S): 3,829 @ $0.38 · Sale (S): 943 @ $0.38 · +3 more | EDGAR |
| 2022-11-02 | 4 | Harbin Stephen — COO and Chief of Staff | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Rubin Eric — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Nam Spencer — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Yanni Barbara — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Finer Mitchell H. — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Fenton Mary Kay — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | Canute Scott A — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | FAMBROUGH DOUGLAS — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2022-06-24 | 4 | EVNIN LUKE — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2022-05-25 | 4 | Wanstall Rick — CFO and Treasurer | Purchase (P): 3,777 @ $1.20 | EDGAR |
| 2022-05-24 | 4 | Wanstall Rick — CFO and Treasurer | Purchase (P): 1,610 @ $1.20 | EDGAR |
| 2022-05-19 | 4 | Wanstall Rick — CFO and Treasurer | Purchase (P): 1 @ $1.20 · Purchase (P): 5,000 @ $1.29 | EDGAR |
| 2022-05-16 | 4 | Wanstall Rick — CFO and Treasurer | Purchase (P): 14,094 @ $1.08 · Purchase (P): 3,898 @ $1.15 · Purchase (P): 20,620 @ $1.18 | EDGAR |
| 2022-05-12 | 4 | Wanstall Rick — CFO and Treasurer | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Goldberg John Mayer — Chief Medical Officer | Grant/award (A): 84,500 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Queva Christophe — CSO and SVP, Research | Grant/award (A): 82,500 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Harbin Stephen — COO and Chief of Staff | Grant/award (A): 87,500 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | McCabe John P. — CFO and Treasurer | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Ashburn Theodore — President and CEO, Director | Grant/award (A): 211,000 (derivative) @ $0 | EDGAR |
| 2021-11-22 | 4 | Ashburn Theodore — President and CEO, Director | Option exercise (M): 32,500 @ $1.81 · Option exercise (M): 32,500 (derivative) @ $0 | EDGAR |
| 2021-11-17 | 4 | Harbin Stephen — COO and Chief of Staff | Purchase (P): 15,000 @ $5.80 · Purchase (P): 15,000 @ $5.78 | EDGAR |
| 2021-10-25 | 4 | Ashburn Theodore — President and CEO, Director | Option exercise (M): 43,707 @ $1.81 · Option exercise (M): 43,707 (derivative) @ $0 | EDGAR |
| 2021-07-29 | 4 | Yanni Barbara — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Nam Spencer — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Harbin Stephen — COO and Chief of Staff | Grant/award (A): 87,125 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Rubin Eric — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Finer Mitchell H. — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Fenton Mary Kay — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | Canute Scott A — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4/A | Canute Scott A — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-06-17 | 4 | EVNIN LUKE — Director, 10% owner | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2021-06-03 | 4 | Queva Christophe — CSO and SVP, Research | Sale (S): 12,899 @ $16.69 · Sale (S): 10,656 @ $16.66 | EDGAR |
| 2021-05-26 | 4 | Queva Christophe — CSO and SVP, Research | Option exercise (M): 35,561 @ $1.81 · Option exercise (M): 35,561 (derivative) @ $0 | EDGAR |
| 2021-05-04 | 4 | Queva Christophe — CSO and SVP, Research | Sale (S): 22,755 @ $15.94 · Sale (S): 800 @ $16.76 | EDGAR |
| 2021-04-28 | 4 | Queva Christophe — CSO and SVP, Research | Sale (S): 54 @ $15 · Sale (S): 211 @ $15 · Sale (S): 17,990 @ $15.22 | EDGAR |
| 2021-04-09 | 4 | Ashburn Theodore — President and CEO, Director | Option exercise (M): 1,900 @ $1.81 · Option exercise (M): 4,699 @ $5.32 · Option exercise (M): 1,900 (derivative) @ $0 · Option exercise (M): 4,699 (derivative) @ $0 | EDGAR |
| 2021-04-08 | 4 | Queva Christophe — CSO and SVP, Research | Sale (S): 5,300 @ $15.01 | EDGAR |
| 2021-03-03 | 4 | Goldberg John Mayer — SVP, Clinical Development | Grant/award (A): 61,063 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Queva Christophe — CSO and SVP, Research | Grant/award (A): 70,109 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | McCabe John P. — CFO, Treasurer and Secretary | Grant/award (A): 76,894 (derivative) @ $0 | EDGAR |
| 2021-03-03 | 4 | Ashburn Theodore — President and CEO, Director | Grant/award (A): 199,000 (derivative) @ $0 | EDGAR |
| 2021-02-18 | 4 | Flynn James E — Director, 10% owner Deerfield Mgmt HIF, L.P. — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — Director, 10% owner Deerfield Healthcare Innovations Fund, L.P. — Director, 10% owner DEERFIELD PARTNERS, L.P. — Director, 10% owner Deerfield Mgmt III, L.P. — Director, 10% owner Deerfield Private Design Fund III, L.P. — Director, 10% owner Deerfield Mgmt L.P. — Director, 10% owner | Purchase (P): 133,558 @ $19 · Purchase (P): 133,558 @ $19 · Purchase (P): 32,884 @ $19 | EDGAR |
| 2020-12-16 | 4 | Canute Scott A — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-12-09 | 4 | Harbin Stephen — COO and Chief of Staff | Grant/award (A): 169,000 (derivative) @ $0 | EDGAR |
| 2020-10-08 | 4 | GADICKE ANSBERT — 10% owner | Conversion (C): 1,783,879 · Conversion (C): 1,525,348 · Conversion (C): 775,975 · Conversion (C): 700,453 · Purchase (P): 173,776 @ $15 · Purchase (P): 151,224 @ $15 · +4 more | EDGAR |
| 2020-10-08 | 4 | Flynn James E — Director, 10% owner Deerfield Mgmt HIF, L.P. — Director, 10% owner DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) — Director, 10% owner Deerfield Healthcare Innovations Fund, L.P. — Director, 10% owner DEERFIELD PARTNERS, L.P. — Director, 10% owner Deerfield Mgmt III, L.P. — Director, 10% owner Deerfield Private Design Fund III, L.P. — Director, 10% owner Deerfield Mgmt L.P. — Director, 10% owner | Conversion (C): 620,480 · Conversion (C): 620,480 · Conversion (C): 202,670 · Conversion (C): 202,670 · Conversion (C): 202,670 · Purchase (P): 445,194 @ $15 · +7 more | EDGAR |
Recent 8-K events — Oncorus, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-08-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2023-07-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2023-07-19 | 8-K | 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-06-26 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-09 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-06-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-01 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-18 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-05-05 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ONCR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs